Predict your next investment

See what CB Insights has to offer

Investments

108

Portfolio Exits

16

Partners & Customers

2

About DSM Venturing

Royal DSM is a global science-based company active in health, nutrition, and materials. By connecting its competences in Life Sciences and Materials Sciences, DSM is driving economic prosperity, environmental progress, and social advances to create sustainable value for all stakeholders. DSM delivers solutions that nourish, protect, and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy, and bio-based materials.

DSM Venturing Headquarter Location

Het Overloon 1

Heerlen, 6411 TE,

Netherlands

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing DSM Venturing

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find DSM Venturing in 1 Expert Collection, including Synthetic Biology.

S

Synthetic Biology

382 items

Latest DSM Venturing News

Natural Food Colorant Developer Phytolon Raises $14.5M

Jul 10, 2022

Phyloton , an Israeli startup that develops natural food colorants, has secured $14.5 million in Series A funding. The Series A funding round was led by DSM Venturing, the corporate venture arm of Royal DSM, a Dutch multinational corporation. New investors Cibus Fund and Ginkgo Bioworks also contributed to the funding round. These investors were supplemented by Phytolon’s existing shareholders, Arkin Holdings, Millennium Foodtech, Trendlines Group, Stern Tech, and OpenValley founder Yossi Ackerman in the funding round. Trendlines Agrifood Fund also took part in the fundraising efforts, offering foundry services as an ‘in-kind’ investment, according to AgFunder News . Phytolon was founded in 2018 by co-founders Halim Jubran and Tal Zeltzer, who both have backgrounds in biotechnology. The company’s technology, licensed from Israel’s Weizmann Institute of Science , provides an alternative to synthetic dyes commonly used in foods and beverages globally. Unique to other natural food-coloring products (which normally stem from fruits and vegetables), Phytolon’s products come from betalain pigments derived from yeast fermentation. Phytolon’s natural food-coloring technology produces a range of natural colors to be used in a range of foods, including dairy, frozen products, snacks, alternative meats, and baked goods. Phytolon is working to develop natural food-coloring products through yeast fermentation. The company plans to use the newly acquired funding to scale up its production and commercialization efforts, with a goal of market entry in 2023 (pending regulatory approval). Phytolon plans to bring its products, first, to US and European markets. Europe is home to the greatest demand for natural food-coloring products. The funding round comes during a period of growth for the global natural food colors industry. The industry, previously valued at $5 billion in 2020, is projected to be valued at $6.8 billion by 2025, AgFunder reports. The industry’s growth is driven by the global consumer desire for clean label products and increased consumer awareness. With artificial food dyes like Red40 posing potential health concerns and allergy threats, the need for natural food colorants is felt by markets worldwide. Phyloton is currently exploring market entry options. Subscribe to NoCamels weekly newsletter and get our top stories

DSM Venturing Investments

108 Investments

DSM Venturing has made 108 investments. Their latest investment was in Phytolon as part of their Series A on July 7, 2022.

CBI Logo

DSM Venturing Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/6/2022

Series A

Phytolon

$14.5M

Yes

3

6/22/2022

Series A

Chinova Bioworks

$6M

No

1

5/25/2022

Series A - II

inne

$10M

Yes

3

3/23/2022

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

10/29/2021

Series B - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/6/2022

6/22/2022

5/25/2022

3/23/2022

10/29/2021

Round

Series A

Series A

Series A - II

Seed VC

Series B - II

Company

Phytolon

Chinova Bioworks

inne

Subscribe to see more

Subscribe to see more

Amount

$14.5M

$6M

$10M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

3

1

3

10

10

DSM Venturing Portfolio Exits

16 Portfolio Exits

DSM Venturing has 16 portfolio exits. Their latest portfolio exit was Voxel8 on August 10, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/10/2021

Acquired

$99M

2

7/28/2021

Acquired

$99M

5

6/16/2021

IPO

$99M

Public

2

5/17/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

2/7/2019

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/10/2021

7/28/2021

6/16/2021

5/17/2021

2/7/2019

Exit

Acquired

Acquired

IPO

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

2

5

2

10

10

DSM Venturing Acquisitions

2 Acquisitions

DSM Venturing acquired 2 companies. Their latest acquisition was Qolpac on January 01, 2009.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

1/1/2009

$99M

Acquired

1

12/19/2000

Grant

Subscribe to see more

$99M

$99M

Subscribe to see more

10

Date

1/1/2009

12/19/2000

Investment Stage

Grant

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

$99M

Note

Acquired

Subscribe to see more

Sources

1

10

DSM Venturing Partners & Customers

2 Partners and customers

DSM Venturing has 2 strategic partners and customers. DSM Venturing recently partnered with IMCD on April 4, 2015.

Date

Type

Business Partner

Country

News Snippet

Sources

4/8/2015

Partner

Netherlands

IMCD Spain enters partnership with DSM for its range of coating resins

IMCD Spain enters partnership with DSM for its range of coating resins .

1

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

4/8/2015

Type

Partner

Partner

Business Partner

Country

Netherlands

United States

News Snippet

IMCD Spain enters partnership with DSM for its range of coating resins

IMCD Spain enters partnership with DSM for its range of coating resins .

Subscribe to see more

Subscribe to see more

Sources

1

10

DSM Venturing Team

5 Team Members

DSM Venturing has 5 team members, including current Chief Financial Officer, Philip Mertens.

Name

Work History

Title

Status

Philip Mertens

Chief Financial Officer

Current

Marcel Lubben

Managing Director

Current

Pieter Wolters

Managing Director

Current

Rolf-Dieter Schwalb

Chief Financial Officer

Former

Marc Schueler

Managing Director

Former

Name

Philip Mertens

Marcel Lubben

Pieter Wolters

Rolf-Dieter Schwalb

Marc Schueler

Work History

Title

Chief Financial Officer

Managing Director

Managing Director

Chief Financial Officer

Managing Director

Status

Current

Current

Current

Former

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.